Tilray Medical Announces New Scientific Publication on Age-Related Patterns of Medical Cannabis Use
April 03, 2024 07:00 ET
|
Tilray Brands, Inc.
Tilray Medical announced a new Tilray led scientific publication, Age-related Patterns of medical Cannabis Use: A Survey of Authorized Patients in Canada.
Tilray Medical Receives Approval for First Medical Cannabis Extract in Portugal
March 14, 2024 07:00 ET
|
Tilray Brands, Inc.
Tilray Medical has received approval for the first medical cannabis extract, Tilray Oral Solution THC 5 CBD 20, in Portugal.
Tilray Provides International Cannabis Update on Milestone German Cannabis Legalization
February 28, 2024 07:00 ET
|
Tilray Brands, Inc.
Tilray is bullish on the positive paradigm shift that the new German drug policy creates for the future of cannabis in Europe.
Tilray Medical Applauds German Bundestag and Landmark Passage of Medical Cannabis Act in Germany
February 23, 2024 10:38 ET
|
Tilray Brands, Inc.
Tilray Medical welcomes the opening of the German medical cannabis market and the positive paradigm shift in German drug policy.
Tilray Medical Expands Commercial Footprint in Europe and Broadens Distribution Across the Czech Republic
April 06, 2023 08:45 ET
|
Tilray Brands, Inc.
COLOGNE, Germany, April 06, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and empowering the worldwide community to live their...
Tilray Launches ‘Take Back Control’ Platform to Provide Women With Free Medical Cannabis Resources
November 18, 2022 07:00 ET
|
Tilray Brands, Inc.
LEAMINGTON, Ontario, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and empowering the...
Tilray Medical Relaunches Cannabis Oral Solution Across Ireland
October 04, 2022 07:00 ET
|
Tilray Brands, Inc.
LEAMINGTON, Ontario and CANTANHEDE, Portugal, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring...
Tilray Medical Receives Approval to Extend Market Authorization in Italy
September 22, 2022 07:00 ET
|
Tilray Brands, Inc.
LEAMINGTON, Ontario and CANTANHEDE, Portugal, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company...
Tilray Medical Receives Verification From the Natural Health Science Foundation in Australia and New Zealand
August 23, 2022 07:00 ET
|
Tilray Brands, Inc.
SYDNEY, Australia, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods...
Tilray Medical Bolsters Market Leading Position in Europe With Market Authorization in Poland
August 17, 2022 07:00 ET
|
Tilray Brands, Inc.
LEAMINGTON, Ontario and CANTANHEDE, Portugal, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and...